Abstract
Purpose
We evaluated the performance of the placental alpha-microglobulin-1 immunoassay (AmniSure®, AT) in cervicovaginal secretions in patients with uncertain rupture of membranes (ROM) and investigated the influence of the examiners experience.
Methods
This prospective cohort study was performed in pregnant women (17–42 weeks of gestation) with signs of possible ROM. Evaluation included clinical assessment, examination for cervical leakage, Nitrazine test and measurement of the amniotic fluid index by ultrasound and AT. ROM occurrence was based on review of the medical records after delivery.
Results
199 women were included. AT had a sensitivity of 94.4%; specificity of 98.6%; positive predictive value, 96.2%; negative predictive value, 98.0%. Clinical assessment showed a sensitivity of 72.2%; specificity of 97.8%; positive predictive value, 92.9%; negative predictive value, 90.6%. AT was more sensitive for diagnosing ROM (p = 0.00596) compared to clinical assessment, independent of the examiners experience. Furthermore, the sole use of AT reduced costs by 58.4% compared to clinical assessment.
Conclusions
AT was more sensitive compared to clinical assessment, independent of the examiners experience and gestational age. Our data extend its use in patients with uncertain ROM. Moreover, AT seems to be a cost-effective approach in the assessment of these patients.
Similar content being viewed by others
References
Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A et al (2000) The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 183(3):738–745
Simhan HN, Canavan TP (2005) Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG 112(Suppl 1):32–37
Aagaard-Tillery KM, Nuthalapaty FS, Ramsey PS, Ramin KD (2005) Preterm premature rupture of membranes: perspectives surrounding controversies in management. Am J Perinatol 22(6):287–297
Gaucherand P, Salle B, Sergeant P, Guibaud S, Brun J, Bizollon CA et al (1997) Comparative study of three vaginal markers of the premature rupture of membranes. Insulin like growth factor binding protein 1 diamine-oxidase pH. Acta Obstet Gynecol Scand 76(6):536–540
Reece EA, Chervenak FA, Moya FR, Hobbins JC (1984) Amniotic fluid arborization: effect of blood, meconium, and pH alterations. Obstet Gynecol 64(2):248–250
Gorodeski IG, Haimovitz L, Bahari CM (1982) Reevaluation of the pH, ferning and nile blue sulphate staining methods in pregnant women with premature rupture of the fetal membranes. J Perinat Med 10(6):286–292
de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL (1994) Value of the fern test to confirm or reject the diagnosis of ruptured membranes is modest in nonlaboring women presenting with nonspecific vaginal fluid loss. Am J Perinatol 11(1):46–50
Carroll SG, Papaioannou S, Nicolaides KH (1995) Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis. Am J Obstet Gynecol 172(5):1427–1435
(2007) ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 109(4):1007–1019
Petrunin DD, Griaznova IM, Petrunina I, Tatarinov I (1977) Immunochemical identification of organ specific human placental alphal-globulin and its concentration in amniotic fluid. Akush Ginekol (Mosk) 1:62–64
Cousins LM, Smok DP, Lovett SM, Poeltler DM (2005) AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol 22(6):317–320
Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK (2007) Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 109(3):634–640
Phelan JP, Ahn MO, Smith CV, Rutherford SE, Anderson E (1987) Amniotic fluid index measurements during pregnancy. J Reprod Med 32(8):601–604
Kishida T, Yamada H, Negishi H, Sagawa T, Makinoda S, Fujimoto S (1996) Diagnosis of premature rupture of the membranes in preterm patients, using an improved AFP kit: comparison with ROM-check and/or Nitrazine test. Eur J Obstet Gynecol Reprod Biol 69(2):77–82
Rochelson BL, Richardson DA, Macri JN (1983) Rapid assay—possible application in the diagnosis of premature rupture of the membranes. Obstet Gynecol 62(4):414–418
Koninckx PR, Trappeniers H, Van Assche FA (1981) Prolactin concentration in vaginal fluid: a new method for diagnosing ruptured membranes. Br J Obstet Gynaecol 88(6):607–610
Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN et al (1991) Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325(10):669–674
Lockwood CJ, Moscarelli RD, Wein R, Lynch L, Lapinski RH, Ghidini A (1994) Low concentrations of vaginal fetal fibronectin as a predictor of deliveries occurring after 41 weeks. Am J Obstet Gynecol 171(1):1–4
Esim E, Turan C, Unal O, Dansuk R, Cengizglu B (2003) Diagnosis of premature rupture of membranes by identification of beta-HCG in vaginal washing fluid. Eur J Obstet Gynecol Reprod Biol 107(1):37–40
Gurbuz A, Karateke A, Kabaca C (2004) Vaginal fluid creatinine in premature rupture of membranes. Int J Gynaecol Obstet 85(3):270–271
Kafali H, Oksuzler C (2007) Vaginal fluid urea and creatinine in diagnosis of premature rupture of membranes. Arch Gynecol Obstet 275(3):157–160
Nama V, Desilva C, Manyonda I (2007) Association between lactate in vaginal fluid and time to spontaneous onset of labour from women with suspected prelabour rupture of the membranes. BJOG 114(5):652–653
Chen FC, Dudenhausen JW (2008) Comparison of two rapid strip tests based on IGFBP-1 and PAMG-1 for the detection of amniotic fluid. Am J Perinatol 25(4):243–246
Martinez de TB, Boulvain M, Dumps P, Bischof P, Meisser A, Irion O (2006) Can we improve the diagnosis of rupture of membranes? The value of insulin-like growth factor binding protein-1. BJOG 113(9):1096–1099
Akercan F, Cirpan T, Kazandi M, Terek MC, Mgoyi L, Ozkinay E (2005) The value of the insulin-like growth factor binding protein-1 in the cervical-vaginal secretion detected by immunochromatographic dipstick test in the prediction of delivery in women with clinically unconfirmed preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 121(2):159–163
Darj E, Lyrenas S (1998) Insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand 77(3):295–297
Rutanen EM, Karkkainen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL (1996) Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 253(1–2):91–101
Tagore S, Kwek K (2010) Comparative analysis of insulin-like growth factor binding protein-1 (IGFBP-1), placental alpha-microglobulin-1 (PAMG-1) and Nitrazine test to diagnose premature rupture of membranes in pregnancy. J Perinat Med 38(6):609–612
Acknowledgments
The AmniSure ROM test™ kits were provided free of charge by Pro Concepta AG, Zug, Switzerland. Pro Concepta AG did not contribute any further funding for this study. We thank A. Schötzau for expert statistical assistance and D.J. Huang for proof reading the manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
O. Lapaire and I. Hösli contributed equally to this work.
Rights and permissions
About this article
Cite this article
Birkenmaier, A., Ries, JJ., Kuhle, J. et al. Placental α-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet 285, 21–25 (2012). https://doi.org/10.1007/s00404-011-1895-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-011-1895-9